GlassScriptPhysician profile
Gary L Barnes
NPI 1467470187
$2,727.69
in general payments reported to CMS, 2019-2025
22 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $467 · 2022: $528 · 2023: $415 · 2024: $883 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,733.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,178.10 | 2021-2025 | Wavewriter Alpha Prime 16, Varithena Administration Pack |
| Medtronic, INC. | $476.37 | 2021-2024 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $186.68 | 2021-2024 | Xtampza |
| Nevro Corp. | $126.34 | 2022-2024 | Senza |
| Scilex Pharmaceuticals INC. | $119.99 | 2021-2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.00 | 2023-2025 | Relistor |
| Abbott Laboratories | $76.07 | 2021-2022 | |
| Saluda Medical Americas, INC. | $75.50 | 2025 | Evoke |
| Nalu Medical, INC. | $55.71 | 2024-2025 | Nalu Neurostimulation System |
| Arbor Pharmaceuticals, INC. | $50.69 | 2021 | |
| Almatica Pharma LLC | $42.57 | 2021 | |
| Abbvie INC. | $34.67 | 2024 | |
| Si-Bone, INC. | $30.70 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $30.63 | 2022-2023 | Seglentis |
| Globus Medical, INC. | $24.04 | 2025 | Omnia |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $22.73 | 2024 | Qutenza |
| Grt US Holding, INC. | $21.51 | 2022 | |
| Lilly USA, LLC | $17.35 | 2024 | Reyvow, Emgality |
| Azurity Pharmaceuticals, INC. | $16.92 | 2025 | Horizant |
| Spr Therapeutics, INC | $16.28 | 2024 | Sprint Pns System |
| Eisai INC. | $15.02 | 2021 | |
| Virtus Pharmaceuticals LLC | $14.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.